Myasthenia gravis is a chronic autoimmune condition that primarily targets the neuromuscular junction. This junction facilitates the conveyance of signals from nerves to muscles, enabling movement. In myasthenia gravis, the body's immune system mistakenly attacks these receptors, resulting weakness and fatigue in the motor units. The manifestation